Regeneron Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$3,884,300
$3,754,300
$3,675,600
$3,028,700
Gross Profit
3,299,700
3,232,700
3,145,400
2,564,400
EBITDA
1,200,900
1,919,300
1,657,400
1,040,600
EBIT
1,055,900
1,782,600
1,522,300
913,700
Net Income
844,600
1,460,000
1,391,600
808,700
Net Change In Cash
3,884,300
3,754,300
3,675,600
3,028,700
Free Cash Flow
922,000
1,417,300
967,600
773,600
Cash
3,118,100
2,506,400
1,995,800
3,090,200
Basic Shares
107,500
107,200
108,600
111,200

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$14,342,900
$14,202,000
$13,117,200
$12,172,900
Gross Profit
12,242,200
12,231,500
12,233,500
10,467,700
EBITDA
5,818,200
5,318,000
4,047,100
5,259,600
EBIT
5,274,500
4,835,100
4,047,100
4,918,200
Net Income
4,504,900
4,412,600
3,953,600
4,338,400
Net Change In Cash
14,342,900
14,202,000
13,117,200
12,172,900
Cost of Revenue
221,300
Free Cash Flow
4,080,500
3,664,600
3,667,600
4,424,800
Cash
3,118,100
2,488,200
2,730,000
3,105,900
Basic Shares
108,600
115,100
113,700
113,500

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$11.44
2025-09-30
$11.83
2025-06-30
$12.89